相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Can hepatitis C virus infection be eradicated in people who inject drugs?
Jason Grebely et al.
ANTIVIRAL RESEARCH (2014)
Trajectories of injecting behavior in the Amsterdam Cohort Study among drug users
Rafael T. Mikolajczyk et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Elimination on the agenda for hepatitis C
Talha Burki
LANCET INFECTIOUS DISEASES (2014)
HCV direct-acting antiviral agents: the best interferon-free combinations
Raymond Schinazi et al.
LIVER INTERNATIONAL (2014)
Benefits of hepatitis C virus treatment: A balance of preventing onward transmission and re-infection
A. S. de Vos et al.
MATHEMATICAL BIOSCIENCES (2014)
Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements
Jason Grebely et al.
CLINICAL INFECTIOUS DISEASES (2013)
Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs
Bart P. Grady et al.
CLINICAL INFECTIOUS DISEASES (2013)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin et al.
HEPATOLOGY (2013)
The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users
Anneke S. De Vos et al.
JOURNAL OF THEORETICAL BIOLOGY (2013)
Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial
Katja Deterding et al.
LANCET INFECTIOUS DISEASES (2013)
Best strategies for global HCV eradication
Liesl M. Hagan et al.
LIVER INTERNATIONAL (2013)
Treatment as prevention and cure towards global eradication of hepatitis C virus
Liesl M. Hagan et al.
TRENDS IN MICROBIOLOGY (2013)
Elimination of HIV by test and treat: a phantom of wishful thinking?
Mirjam E. E. Kretzschmar et al.
AIDS (2012)
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations
Natasha K. Martin et al.
HEPATOLOGY (2012)
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
Jason Grebely et al.
LANCET INFECTIOUS DISEASES (2012)
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia
Margaret E. Hellard et al.
MEDICAL JOURNAL OF AUSTRALIA (2012)
Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users
Anneke S. de Vos et al.
EPIDEMICS (2012)
Trajectories of Injection Drug Use Over 20 Years (1988-2008) in Baltimore, Maryland
Becky L. Genberg et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Can Hepatitis C virus treatment be used as a prevention strategy? Additional model projections for Australia and elsewhere
Peter Vickerman et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project
Catharina E. A. Lindenburg et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility
Natasha K. Martin et al.
JOURNAL OF HEPATOLOGY (2011)
Optimal Control of Hepatitis C Antiviral Treatment Programme Delivery for Prevention amongst a Population of Injecting Drug Users
Natasha K. Martin et al.
PLOS ONE (2011)
Prospective Follow-Up of Patients with Acute Hepatitis C Virus Infection in Brazil
Lia L. Lewis-Ximenez et al.
CLINICAL INFECTIOUS DISEASES (2010)
Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs
Irmgard Zeiler et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
William O. Osburn et al.
GASTROENTEROLOGY (2010)
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
Deborah Donnell et al.
LANCET (2010)
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
Margaret Hellard et al.
CLINICAL INFECTIOUS DISEASES (2009)
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Reuben M. Granich et al.
LANCET (2009)
Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?
Graham R. Foster
ADDICTION (2008)
Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: Correlates, prevention opportunities, and the role of the environment
Morgan Philbin et al.
AIDS AND BEHAVIOR (2008)
Trajectories of heroin addiction - Growth mixture modeling results based on a 33-year follow-up study
Yih-Ing Hser et al.
EVALUATION REVIEW (2007)
Distributive syringe sharing among young adult injection drug users in five US cities
Elizabeth T. Golub et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
Charlotte Van den Berg et al.
ADDICTION (2007)
Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study
P. Vickerman et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
C Smit et al.
AIDS (2006)
Surveillance of HIV, hepatitis B virus, and hepatitis c virus in an Estonian injection drug-using population:: Sensitivity and specificity of testing syringes for public health surveillance
A Uusküla et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
JM Micallef et al.
JOURNAL OF VIRAL HEPATITIS (2006)